Personalized medicine: predicting responses to therapy in patients with RA-Reference-Cited by-同舟云学术

Personalized medicine: predicting responses to therapy in patients with RA

Published:2013-06 Issue:3 Volume:13 Page:463-469
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

van den Broek Marianne,Visser Karen,Allaart Cornelia F,Huizinga Tom WJ

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference35 articles.

1. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis;Vastesaeger;Rheumatology (Oxford),2009

2. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial;Goekoop-Ruiterman;Arthritis Rheum,2005

3. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study;Visser;Ann Rheum Dis,2010

4. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort;Fautrel;Arthritis Res Ther,2012

5. The performance of matrix-based risk models for rapid radiographic progression in BRASS, a cohort of patients with established rheumatoid arthritis;Lillegraven;Arthritis Care Res (Hoboken),2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tapering of disease-modifying antirheumatic drugs: an overview for daily practice;The Lancet Rheumatology;2021-09

2. Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis;The Pharmacogenomics Journal;2020-03-03

3. Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment;BMC Rheumatology;2019-06-13

4. High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis;The Patient - Patient-Centered Outcomes Research;2018-11-28

5. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews;Health Technology Assessment;2018-11